Brown, Lisle/Cummings’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05K Sell
5
-20
-80% -$4.29K ﹤0.01% 949
2026
Q1
$5.53K Buy
25
+23
+1,150% +$5.63K ﹤0.01% 663
2025
Q4
$507 Hold
2
﹤0.01% 721
2025
Q3
$495 Hold
2
﹤0.01% 743
2025
Q2
$480 Hold
2
﹤0.01% 753
2025
Q1
$453 Buy
+2
New +$440 ﹤0.01% 759

Other funds holding STE

Brown, Lisle/Cummings's STE Position: Q2 2026 in Review

Brown, Lisle/Cummings reduced its Steris (STE) stake by 80% in Q2 2026, selling an estimated $4.29K and leaving 5 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

Brown, Lisle/Cummings first reported a position in STE in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.53K in Q1 2026. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Brown, Lisle/Cummings held 5 shares of Steris worth $1.05K as of Q2 2026.
  • Brown, Lisle/Cummings sold 20 Steris shares in Q2 2026, an estimated $4.29K.
  • Steris made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #949 holding.
  • Brown, Lisle/Cummings first reported a position in Steris in Q1 2025 and has held it in 6 quarters since.
  • Brown, Lisle/Cummings's Steris position peaked at $5.53K in Q1 2026.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.